enVVeno Medical Corporati... (NVNO)
NASDAQ: NVNO
· Real-Time Price · USD
4.63
0.13 (2.89%)
At close: Aug 15, 2025, 2:34 PM
enVVeno Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.82M | -4.5M | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M | -5M | -6.47M | -6.39M | -6.18M | -6.1M | -7.06M | -5.33M | -8.99M | -2.39M | -2.38M | -2.77M |
Depreciation & Amortization | 144.5K | 122K | 122K | 129K | 136K | 141K | 134K | 138K | 138K | 136K | 130K | 133K | 133K | 129K | 121.59K | 120.14K | 107.5K | 103.68K |
Stock-Based Compensation | 1.89M | 651K | 1.02M | 1M | 1M | 1.11M | 1.14M | 1.1M | 1.16M | 1.79M | 2.24M | 2.27M | 2.24M | 2.24M | 5.34M | 325K | 202.12K | 129.16K |
Other Working Capital | n/a | n/a | -424K | -328K | -247K | 120K | 4K | -125K | -174K | -100K | 65K | 40K | 152K | -313K | 334.93K | 16.32K | -121.42K | -541.93K |
Other Non-Cash Items | 1.12M | -288K | 408K | -3K | 1.07M | 1.24M | -5.04M | -2.21M | 7.06M | -277K | -256K | -240K | 103K | -47K | -76.96K | -78.55K | -78.55K | -78.55K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 5.14M | 2.05M | -7.2M | n/a | n/a | n/a | n/a | n/a | n/a | -312.7K | n/a | n/a |
Change in Working Capital | 602.75K | n/a | -424K | 240K | -46K | 230K | -701K | -297K | 750K | -368K | 212K | -655K | 629K | -316K | 500.82K | 101.63K | -524.2K | -1.22M |
Operating Cash Flow | -5.06M | -4.02M | -5.11M | -4.28M | -3.91M | -3.55M | -4.97M | -4.21M | -4.56M | -5.11M | -3.86M | -4.48M | -3.96M | -3.32M | -3.1M | -2.23M | -2.67M | -3.84M |
Capital Expenditures | 121.48K | n/a | -4K | -9K | -14K | -10K | -4K | -3K | -21K | -5K | -9K | -14K | -23K | -69K | -64.75K | -152.63K | -126.48K | -24.03K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 14.3K | -4.45K | -7.03K | -2.83K | -5.53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -16.81M | -8.87M | -22.15M | -8.35M | -9.93M | -15.13M | -32.24M | -9.18M | -6.47M | -8.63M | -5.91M | -3.93M | -38.29M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 24.84M | 14.07M | 11.1M | 14.58M | 13.92M | 17.34M | 10.1M | 13.63M | 13.5M | 11.46M | 11.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 3.99M | 2.21M | -14.3K | 4.45K | 7.03K | 2.83K | 5.53K | -1.68M | -38.29K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 8.15M | 5.2M | -11.06M | 6.22M | 3.97M | 2.2M | -22.14M | 4.45M | 7M | 2.83M | 5.52M | -1.69M | -38.31M | -69K | -64.75K | -152.63K | -126.48K | -24.03K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 13.59M | n/a | 46K | 25.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50 | 18.27M | n/a | 239.78K |
Financial Cash Flow | n/a | n/a | n/a | 13.59M | n/a | 46K | 25.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.05K | 19.24M | n/a | 38.37M |
Net Cash Flow | -39M | 1.18M | -16.16M | 15.54M | 66K | -1.31M | -1.33M | 232K | 2.44M | -2.28M | 1.66M | -6.17M | -42.27M | -3.39M | -3.17M | 16.86M | -2.8M | 34.5M |
Free Cash Flow | -4.94M | -4.02M | -5.11M | -4.29M | -3.92M | -3.56M | -4.98M | -4.22M | -4.58M | -5.11M | -3.87M | -4.5M | -3.98M | -3.39M | -3.16M | -2.39M | -2.8M | -3.87M |